- Conditions
- APC Gene Mutation, ATM Gene Mutation, BARD1 Gene Mutation, +19 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activity) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
Clinical trial condition
POLE Gene Mutation
Explore clinical trials studying POLE Gene Mutation. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
POLE Gene Mutation trial results
Active, Not Recruiting
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
NCT03428802
- Conditions
- Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +40 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States